Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02023372 · ClinicalTrials.gov registry record · NA

Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine

A NA study of Spondylolisthesis and Spinal Stenosis, sponsored by NuTech Medical.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT02023372 is a NA study of Spondylolisthesis and Spinal Stenosis that has completed, run by NuTech Medical. The registered enrollment target is 57 participants, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02023372, a NA study of Spondylolisthesis and Spinal Stenosis, has completed, sponsored by NuTech Medical.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether NuCel is effective in promoting spinal fusion in degenerative disease of the lumbar spine.

Interventions

  • OTHER NuCel with Autograft

Study Locations (1)

North Carolina

  • Carolina NeuroSurgery and Spine - Charlotte

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2013-12
Est. Completion 2019-08-16
Phase NA

Sponsor

NuTech Medical

6 total trials

What the Registry Record Tells You About NCT02023372

The ClinicalTrials.gov registry entry for NCT02023372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 150-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (62% lower). The listed sponsor is NuTech Medical, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Spondylolisthesis appearing as the primary indexed condition, and to 1 intervention - of which NuCel with Autograft is the first listed.

NCT02023372 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02023372 about?

NCT02023372 is a clinical study titled "Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine". The purpose of this study is to determine whether NuCel is effective in promoting spinal fusion in degenerative disease of the lumbar spine.

What is the current status of trial NCT02023372?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2013-12. Estimated completion is 2019-08-16.

What conditions does trial NCT02023372 study?

This clinical trial studies the following conditions: Spondylolisthesis, Spinal Stenosis, Spondylosis, Intervertebral Disc Degeneration, Intervertebral Disc Disease.

What interventions are being tested in trial NCT02023372?

The interventions under investigation include: NuCel with Autograft (OTHER).

Who is sponsoring clinical trial NCT02023372?

This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02023372 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolisthesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.